BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21393247)

  • 1. Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice.
    Obrador E; Benlloch M; Pellicer JA; Asensi M; Estrela JM
    J Biol Chem; 2011 May; 286(18):15716-27. PubMed ID: 21393247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.
    Valles SL; Benlloch M; Rodriguez ML; Mena S; Pellicer JA; Asensi M; Obrador E; Estrela JM
    J Transl Med; 2013 Mar; 11():72. PubMed ID: 23517603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver.
    Obrador E; Carretero J; Ortega A; Medina I; Rodilla V; Pellicer JA; Estrela JM
    Hepatology; 2002 Jan; 35(1):74-81. PubMed ID: 11786961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity.
    Benlloch M; Ortega A; Ferrer P; Segarra R; Obrador E; Asensi M; Carretero J; Estrela JM
    J Biol Chem; 2005 Feb; 280(8):6950-9. PubMed ID: 15561710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity.
    Obrador E; Valles SL; Benlloch M; Sirerol JA; Pellicer JA; Alcácer J; Coronado JA; Estrela JM
    PLoS One; 2014; 9(5):e96466. PubMed ID: 24802641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium.
    Ortega A; Ferrer P; Carretero J; Obrador E; Asensi M; Pellicer JA; Estrela JM
    J Biol Chem; 2003 Oct; 278(41):39591-9. PubMed ID: 12881529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.
    Palomares T; Alonso-Varona A; Alvarez A; Castro B; Calle Y; Bilbao P
    Clin Exp Metastasis; 1997 May; 15(3):329-37. PubMed ID: 9174132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
    Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
    Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells.
    Yang CH; Yue J; Pfeffer SR; Handorf CR; Pfeffer LM
    J Biol Chem; 2011 Nov; 286(45):39172-8. PubMed ID: 21940630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy.
    Benlloch M; Mena S; Ferrer P; Obrador E; Asensi M; Pellicer JA; Carretero J; Ortega A; Estrela JM
    J Biol Chem; 2006 Jan; 281(1):69-79. PubMed ID: 16263711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases.
    Bilbao P; del Olmo M; Alonso-Varona A; Castro B; Bilbao J; Palomares T
    Melanoma Res; 2002 Feb; 12(1):17-26. PubMed ID: 11828254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion.
    Navarini AL; Chiaradia LD; Mascarello A; Fritzen M; Nunes RJ; Yunes RA; Creczynski-Pasa TB
    Eur J Med Chem; 2009 Apr; 44(4):1630-7. PubMed ID: 19211173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular glutathione and its metabolizing enzyme activities in a metastatic variant melanoma cell line.
    Chakraborty AK; Ueda M; Mishima Y; Ichihashi M
    Melanoma Res; 1992 Dec; 2(5-6):315-9. PubMed ID: 1363379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1.
    Watts RN; Hawkins C; Ponka P; Richardson DR
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7670-5. PubMed ID: 16679408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity.
    Landreville S; Agapova OA; Kneass ZT; Salesse C; Harbour JW
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):430-7. PubMed ID: 21575142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells.
    Carretero J; Obrador E; Anasagasti MJ; Martin JJ; Vidal-Vanaclocha F; Estrela JM
    Clin Exp Metastasis; 1999; 17(7):567-74. PubMed ID: 10845555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.
    Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J
    Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
    Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
    Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop.
    Yi M; Wang W; Chen S; Peng Y; Li J; Cai J; Zhou Y; Peng Q; Ban Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    Mol Biol Rep; 2018 Oct; 45(5):1277-1287. PubMed ID: 30074127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of thymosin beta4 in tumor metastasis and angiogenesis.
    Cha HJ; Jeong MJ; Kleinman HK
    J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.